Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6150985rdf:typepubmed:Citationlld:pubmed
pubmed-article:6150985lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:6150985lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:6150985lifeskim:mentionsumls-concept:C0042396lld:lifeskim
pubmed-article:6150985lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:6150985lifeskim:mentionsumls-concept:C0028066lld:lifeskim
pubmed-article:6150985lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:6150985lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:6150985pubmed:issue11lld:pubmed
pubmed-article:6150985pubmed:dateCreated1985-2-14lld:pubmed
pubmed-article:6150985pubmed:abstractTextThe sensitivity of the increase in diastolic pressure brought about by the selective agonists of alpha 2-adrenoceptors, B-HT 920, B-HT 933, xylazine, UK-14,304, M-7, TL-99 and DP-6, 7-ADTN in pithed normotensive rats to blockade by the calcium entry inhibitor nifedipine has been investigated. To exclude any participation of vascular alpha 1- and beta 2-adrenoceptors, as well as cardiac beta 1-adrenoceptors, in the pressor responses, the study was made after treatment of the pithed rats with prazosin (0.1 mg kg-1) and (-)-propranol (1 mg kg-1). Without exception, the preferential agonists of alpha 2-adrenoceptors elicited vasoconstrictor responses which were susceptible to inhibition by nifedipine (0.03-1 mg kg-1) in a dose-dependent manner regardless of the differences in intrinsic activity of the compounds. The pressor activity was almost completely abolished after 1 mg kg-1 of nifedipine. The results show that vasoconstriction induced in pithed rats by various selective stimulating agents of postjunctional vascular alpha 2-adrenoceptors is invariably and equally sensitive to attenuation by nifedipine. This susceptibility of alpha 2-adrenoceptor-mediated vasoconstriction to impairment by blockade of calcium entry is not dependent on the nature, the potency or the efficacy of the agonist.lld:pubmed
pubmed-article:6150985pubmed:languageenglld:pubmed
pubmed-article:6150985pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6150985pubmed:citationSubsetIMlld:pubmed
pubmed-article:6150985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6150985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6150985pubmed:statusMEDLINElld:pubmed
pubmed-article:6150985pubmed:monthNovlld:pubmed
pubmed-article:6150985pubmed:issn0022-3573lld:pubmed
pubmed-article:6150985pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:6150985pubmed:authorpubmed-author:TimmermansP...lld:pubmed
pubmed-article:6150985pubmed:authorpubmed-author:de JongeAAlld:pubmed
pubmed-article:6150985pubmed:authorpubmed-author:MathyM JMJlld:pubmed
pubmed-article:6150985pubmed:authorpubmed-author:WilffertBBlld:pubmed
pubmed-article:6150985pubmed:authorpubmed-author:ThoolenM JMJlld:pubmed
pubmed-article:6150985pubmed:issnTypePrintlld:pubmed
pubmed-article:6150985pubmed:volume36lld:pubmed
pubmed-article:6150985pubmed:ownerNLMlld:pubmed
pubmed-article:6150985pubmed:authorsCompleteYlld:pubmed
pubmed-article:6150985pubmed:pagination772-5lld:pubmed
pubmed-article:6150985pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:meshHeadingpubmed-meshheading:6150985-...lld:pubmed
pubmed-article:6150985pubmed:year1984lld:pubmed
pubmed-article:6150985pubmed:articleTitleInvariable susceptibility to blockade by nifedipine of vasoconstriction to various alpha 2-adrenoceptor agonists in pithed rats.lld:pubmed
pubmed-article:6150985pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6150985lld:pubmed